1. business and industrial

Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Persistence Market Research
Global Cancer Supportive Care Products
Market is projected to expand at a CAGR of
4.3% by 2015–2021 - Persistence Market
Research
Persistence Market Research
1
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Persistence Market Research Released New Market Report “Global Cancer Supportive
Care Products Market - High consumption of Erythropoietin Stimulating Agents to
drive the market for Global Cancer Supportive Care Drugs,” the global cancer
supportive care products market is projected to expand at a CAGR of 4.3% during the
forecast period (2015–2021).
Cancer supportive care products are mainly used in the treatment of adverse effects
associated with cancer therapy as well as for treatment of symptoms and signs of cancer,
such as chemotherapy-induced nausea and vomiting, chemotherapy induced neutropenia
and anemia, bone metastasis, hair loss, etc. The cancer supportive care products market
accounted for US$ 23, 6002.0 Mn in 2014 and is expected to increase to US$ 31,700.0 Mn by
2021 at a CAGR of 4.3% over the forecast period.
Request Customize Full TOC: http://www.persistencemarketresearch.com/toc/5336
The market for cancer supportive care products, though shrouded by the loss of brands
exclusivity of various generic drugs and entry of biosimilar drugs, presents lucrative
opportunity, as they offer ease of accessibility, affordability, and administration to potential
customers.
The report analyzes the global cancer supportive care products market in terms of market
value (US$ Mn), by drug class, disease indication, region, and distribution channels, and
provides information regarding regional market dynamics, regulations, PEST analysis,
competitive landscape, current trends, market estimations, and forecast.
Among the drug class segments, erythropoietin stimulating agents, such as NeoRecormon,
Procrit, and Arsanep, are expected to account for the largest share of the global cancer
supportive care products market, followed by granulocyte colony-stimulating factors and
others. The erythropoietin stimulating agents segment is expected to gain traction in the
near future due to increasing number of patients suffering from chemotherapy-induced
neutropenia (low count of neutrophils). Increasing demand for high-quality cancer supportive
Persistence Market Research
2
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
care
products
pharmaceutical
is also
influencing
ingredients
and
manufacturers to
maintain
a
sterile
opt for
better quality
microbial
active
contamination-free
manufacturing space.
By disease indication type, the cancer supportive care products market is segmented into
various forms of cancers, such as lung cancer, breast cancer, prostate cancer, etc. Among
these, the lung cancer segment is expected to dominate the overall market in future, i.e. by
2021, owing to greater incidences of tobacco smoking cases, rising pollution, and exposure
to harmful chemicals and gases released from various industries. The segment is projected
to expand at a substantial growth rate over the forecast period. However, breast cancer is
also gaining traction due to changing lifestyle, the rise in adoption of hormone replacement
therapy, and genetic inheritance of genes such as BRCA1 and BRCA2.
Request Sample Report: http://www.persistencemarketresearch.com/samples/5336
Key market participants covered in the report include Amgen Inc., Johnson & Johnson,
Novartis Ag., Baxter International Inc, Fagron Group BV, Teva Pharmaceuticals Industries Ltd,
Hoffmann LA- Roche Ltd, APR Applied Pharma Science Research S.A., Acacia Pharma Ltd, and
Kyowa Hakko Kirin Co Ltd.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/cancersupportive-care-products-market.asp
The cancer supportive care products market is segmented as follows:
By Drug Class

Non-steroidal anti-inflammatory drugs

Anti-infective

Anti-emetics

Monoclonal antibodies
Persistence Market Research
3
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%

Erythropoietin stimulating agents

Opioid analgesics

Bisphosphonates

Granulocyte colony stimulating factors
By Disease Indication

Lung cancer

Breast cancer

Prostate cancer

Liver cancer

Bladder cancer

Leukemia

Ovarian cancer

Melanoma

Others
By Distribution Channel

Hospital pharmacies

Retail pharmacies

Compounding pharmacies
By Region

North America

Latin America

Europe

Asia Pacific

The Middle East & Africa
Persistence Market Research
4
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Market History:
Progress in cancer treatment procedures, with it, has brought challenges that go beyond
cure. Toxicity and morbidity are among the biggest hurdles that a cancer patient has to face
while undergoing chemotherapy or radiation therapy. Host of path-breaking technological
advancements have been made in the science of supportive care for treating chemotherapy
induced side effects, such as bone metastasis, cancer pain, oral mucositis, chemotherapy
induced neutropenia, chemotherapy induced nausea and vomiting, chemotherapy induced
anemia, and various signs and symptoms associated with it. Cancer supportive care
products or drugs are used in the treatment of side effects as well as various signs and
symptoms associated with chemotherapy. Drugs used for the treatment of chemotherapy
induced side effects belong to one of the drug classes mentioned below: non-steroidal antiinflammatory drugs, anti-infective, anti-emetics, monoclonal antibodies, erythropoietin
stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony stimulating
factors.
Globally, cancer supportive care products market is estimated to account for a market value
of US$ 24,620 Mn by the end of 2015, and it is projected to witness stable growth across all
global regions, due to rising incidences of cancer, leading to increasing demand for effective
cancer supportive care products.
The primary growth driver for the cancer supportive care products market are the rising
incidences of various forms of cancers worldwide. According to Globocan 2012, there were
14.1 Mn cancer cases estimated worldwide in 2012. Lung cancer was seen to be the most
common cancer worldwide among men, accounting for nearly 17% of the total number of
new cases diagnosed in 2012. Furthermore, greater effectiveness of anti-cancer drugs, such
as anti-emetics drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), opioid analgesics
drugs, etc., has been driving the growth of the global cancer supportive care products
market over the last few years. These drugs help prevent side-effects of cancer treatment on
the patient, due to which adoption rate of these cancer supportive care drugs has been on
the rise.
Manufacturers of cancer supportive care products are more focused on innovation and
development of new drugs to maintain a competitive advantage in the market. Many
Persistence Market Research
5
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
manufacturers have introduced various new drugs for the treatment of cancer and for
therapeutic approaches, including preventive vaccines and cancer supportive care products.
Over the last two years, 21 new molecular entities have been launched. These new
medicines have increased the possibility of treating cancer, leading to more combination
therapies and additional lines of therapy.
The rise in overall healthcare expenditure is also expected to contribute to the overall
growth of the cancer supportive care products market in the coming years. Healthcare
expenditure in the U.S. is projected to grow at an average annual rate of 5.8% during the
forecast period. By 2022, healthcare spending in the country is projected to account for
around 19.9% of its GDP. This is expected to boost the overall healthcare spending by
patients suffering from cancer in the country.
Globally, the market in North America is expected to expand at the strongest CAGR in terms
of value throughout the forecast period. The U.S. market in North America is estimated to
witness a single digit growth during the forecast period. Higher healthcare spending and
rising number of initiatives by the government to improve access to various drugs and
increase adherence, along with direct-to-consumer marketing in the U.S., are factors that are
expected to continue to further drive demand for the cancer supportive care products and,
thus, lead to standardization of the market in the region. Currently, erythropoietin
stimulating agents segment dominates the region in terms of drug class popularity.
However, cost issues and lack of reimbursement policies are expected to slightly hamper the
growth of the market in North America during the forecast period.
Europe is the second-most lucrative destination for cancer supportive care products
currently. Absence of post-treatment patient care in Eastern Europe is expected to affect the
overall market for supportive cancer care products in the region over the next few years.
The Europe market is expected to expand at a stable CAGR over the forecast period. Major
companies based in Europe are looking to expand their base outside Europe to better cater
to growing global demand for cancer supportive care products.
Brazil is expected to contribute the largest market share in the Latin America cancer
supportive care product market and is expected to witness stable growth in terms of market
value during the forecast period. However, late diagnosis of cancer that leads to
epidemiological transition, wherein the cancer shifts from being an infectious disease to a
Persistence Market Research
6
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
chronic disease, is a factor expected to restrict the growth of the overall cancer supportive
care products market in Latin America.
Globally, the Asia-Pacific market is expected to expand at the highest CAGR, followed by
North America, Europe, and Latin America. The Middle East & Africa accounts for a nominal
share of the overall cancer supportive care products market currently but is expected to
evolve over time with the expansion of infrastructural healthcare facilities and skill base of
pharmacists in the region.
Key market participants covered in the report include Amgen Inc., Johnson & Johnson,
Novartis Ag., Baxter International Inc, Fagron Group BV, Teva Pharmaceuticals Industries Ltd,
Hoffmann LA- Roche Ltd, APR Applied Pharma Science Research S.A., Acacia Pharma Ltd, and
Kyowa Hakko Kirin Co Ltd.
Persistence Market Research
7
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Table of Content
1. Executive Summary
2. Research Methodology
3. Assumption & Acronyms Used
4. Market Overview
4.1. Parent Market Overview
4.2. Market Taxonomy & Market Definition
4.3. Global Cancer Supportive Care Products Market Size and Forecast
4.3.1. Introduction
4.3.2. Market Value Forecast & Y-o-Y Growth Rate (2015-2021)
4.4. Global Cancer Supportive Care Products Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Trends
4.4.4. Opportunity
5. Regulations & PEST Analysis
6. Global Cancer Supportive Care Products Market Analysis and Forecast By Drug
Class
6.1.1. Introduction
6.1.2. Y-o-Y Growth Comparison, By Drug Class
6.1.3. BPS Analysis, By Drug Class
6.1.3.1. Nonsteroidal Anti-inflammatory Drugs
6.1.3.2. Anti-infective
6.1.3.3. Anti-emetics
6.1.3.4. Monoclonal Antibodies
6.1.3.5. Erythropoietin Stimulating Agents
6.1.3.6. Opioid Analgesics
6.1.3.7. Bisphosphonates
6.1.3.8. Granulocyte Colony Stimulating Factor
Persistence Market Research
8
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
6.1.4. Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug
Class
7. Global Cancer Supportive Care Products Market Analysis and Forecast By
Indication
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By Indication
7.1.2. BPS Analysis, By Indication
7.1.2.1. Lung Cancer
7.1.2.2. Breast Cancer
7.1.2.3. Prostate Cancer
7.1.2.4. Liver Cancer
7.1.2.5. Bladder Cancer
7.1.2.6. Leukaemia
7.1.2.7. Ovarian Cancer
7.1.2.8. Melanoma
7.1.2.9. Other Cancer
7.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By
Indication
8. Cancer Supportive Care Products Market Analysis and Forecast By Distribution
Channel
8.1. Introduction
8.1.1. Y-o-Y Growth Comparison, By Distribution Channel
8.1.2. BPS Analysis, By Distribution Channel
8.1.2.1. Hospital Pharmacies
8.1.2.2. Retail Pharmacies
8.1.2.3. Compounding Pharmacies
8.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel
9. Global Cancer Supportive Care Products Market Analysis and Forecast By
Region
9.1. Introduction
9.1.1. Y-o-Y Growth Comparison, By Region
Persistence Market Research
9
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
9.1.2. BPS Analysis, By Region
9.1.2.1. North America
9.1.2.2. Latin America
9.1.2.3. Europe
9.1.2.4. Asia Pacific
9.1.2.5. MEA
9.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Region
10. North America Cancer Supportive Care Products Market Analysis
10.1. Introduction
10.2. U.S.
10.2.1. Market Value & Y-o-Y Growth
10.2.2. Absolute $ Opportunity
10.3. Canada
10.3.1. Market Value & Y-o-Y Growth
10.3.2. Absolute $ Opportunity
10.4. North America Cancer Supportive Care Products Market Value By Drug Class
10.5. North America Cancer Supportive Care Products Market Value By Disease Indication
10.6. North America Cancer Supportive Care Products Market Value By Distribution Channel
10.7. North America Cancer Supportive Care Products Market Attractiveness Analysis By
Drug Class
10.8. North America Cancer Supportive Care Products Market Attractiveness Analysis By
Indication
10.9. North America Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel
10.10. North America Cancer Supportive Care Products Market Attractiveness Analysis By
Country
11. Latin America Cancer Supportive Care Products Market Analysis
11.1. Introduction
11.2. Argentina
11.2.1. Market Value & Y-o-Y Growth
11.2.2. Absolute $ Opportunity
11.3. Brazil
11.3.1. Market Value & Y-o-Y Growth
Persistence Market Research
10
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
11.3.2. Absolute $ Opportunity
11.4. Mexico
11.4.1. Market Value & Y-o-Y Growth
11.4.2. Absolute $ Opportunity
11.5. Rest of Latin America
11.5.1. Market Value & Y-o-Y Growth
11.5.2. Absolute $ Opportunity
11.6. Latin America Cancer Supportive Care Products Market Value By Drug Class
11.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication
11.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel
11.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug
Class
11.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By
Indication
11.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel
11.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By
Country
12. Latin America Cancer Supportive Care Products Market Analysis
12.1. Introduction
12.2. Argentina
12.2.1. Market Value & Y-o-Y Growth
12.2.2. Absolute $ Opportunity
12.3. Brazil
12.3.1. Market Value & Y-o-Y Growth
12.3.2. Absolute $ Opportunity
12.4. Mexico
12.4.1. Market Value & Y-o-Y Growth
12.4.2. Absolute $ Opportunity
12.5. Rest of Latin America
12.5.1. Market Value & Y-o-Y Growth
12.5.2. Absolute $ Opportunity
12.6. Latin America Cancer Supportive Care Products Market Value By Drug Class
12.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication
Persistence Market Research
11
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
12.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel
12.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug
Class
12.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By
Indication
12.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel
12.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By
Country
13. Europe Cancer Supportive Care Products Market Analysis
13.1. Introduction
13.2. Germany
13.2.1. Market Value & Y-o-Y Growth
13.2.2. Absolute $ Opportunity
13.3. U.K.
13.3.1. Market Value & Y-o-Y Growth
13.3.2. Absolute $ Opportunity
13.4. France
13.4.1. Market Value & Y-o-Y Growth
13.4.2. Absolute $ Opportunity
13.5. Italy
13.5.1. Market Value & Y-o-Y Growth
13.5.2. Absolute $ Opportunity
13.6. Spain
13.6.1. Market Value & Y-o-Y Growth
13.6.2. Absolute $ Opportunity
13.7. Nordic
13.7.1. Market Value & Y-o-Y Growth
13.7.2. Absolute $ Opportunity
13.8. Russia
13.8.1. Market Value & Y-o-Y Growth
13.8.2. Absolute $ Opportunity
13.9. Rest of Europe
13.9.1. Market Value & Y-o-Y Growth
Persistence Market Research
12
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
13.9.2. Absolute $ Opportunity
13.9.3.
13.10. Europe Cancer Supportive Care Products Market Value By Drug Class
13.11. Europe Cancer Supportive Care Products Market Value By Disease Indication
13.12. Europe Cancer Supportive Care Products Market Value By Distribution Channel
13.13. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Drug
Class
13.14. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Indication
13.15. Europe Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel
13.16. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Country
14. Asia Pacific Cancer Supportive Care Products Market Analysis
14.1. Introduction
14.2. Greater China
14.2.1. Market Value & Y-o-Y Growth
14.2.2. Absolute $ Opportunity
14.3. India
14.3.1. Market Value & Y-o-Y Growth
14.3.2. Absolute $ Opportunity
14.4. Japan
14.4.1. Market Value & Y-o-Y Growth
14.4.2. Absolute $ Opportunity
14.5. Australia and New Zealand
14.5.1. Market Value & Y-o-Y Growth
14.5.2. Absolute $ Opportunity
14.6. Rest of APAC
14.6.1. Market Value & Y-o-Y Growth
14.6.2. Absolute $ Opportunity
14.7. Asia Pacific Cancer Supportive Care Products Market Value By Drug Class
14.8. Asia Pacific Cancer Supportive Care Products Market Value By Disease Indication
14.9. Asia Pacific Cancer Supportive Care Products Market Value By Distribution Channel
14.10. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Drug
Class
Persistence Market Research
13
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
14.11. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By
Indication
14.12. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel
14.13. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By
Country
15. MEA Cancer Supportive Care Products Market Analysis
15.1. Introduction
15.2. GCC
15.2.1. Market Value & Y-o-Y Growth
15.2.2. Absolute $ Opportunity
15.3. South Africa
15.3.1. Market Value & Y-o-Y Growth
15.3.2. Absolute $ Opportunity
15.4. Rest of MEA
15.4.1. Market Value & Y-o-Y Growth
15.4.2. Absolute $ Opportunity
15.5. MEA Cancer Supportive Care Products Market Value By Drug Class
15.6. MEA Cancer Supportive Care Products Market Value By Disease Indication
15.7. MEA Cancer Supportive Care Products Market Value By Distribution Channel
15.8. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
15.9. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Indication
15.10. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Distribution
Channel
15.11. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Country
16. Competitive Landscape
16.1. Amgen Inc.
16.2. Johnson & Johnson Private Ltd.
16.3. Novartis AG
16.4. Baxter International Inc
16.5. Hoffmann-La Roche Ltd.
16.6. Fagron Group BV
16.7. Teva Pharmaceutical Industries Ltd.
Persistence Market Research
14
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
List of Tables
Table 01: Global Cancer Supportive Care Products Market Value by Drug Class, 2015–2021
(US$ Mn)
Table 02: Global Cancer Supportive Care Products Market Value By Disease Indication, 2015–
2021 (US$ Mn)
Table 03: Global Cancer Supportive Care Products Market Value By Distribution Channel,
2015–2021 (US$ Mn)
Table 04: North America Cancer Supportive Care Products Market Value by Drug Class, 2015–
2021 (US$ Mn)
Table 05: North America Cancer Supportive Care Products Market Value By Disease
Indication, 2015–2021 (US$ Mn)
Table 06: North America Cancer Supportive Care Products Market Value By Distribution
Channel, 2015–2021 (US$ Mn)
Table 07: Latin America Cancer Supportive Care Products Market Value by Drug Class, 2015–
2021 (US$ Mn)
Table 08: Latin America Cancer Supportive Care Products Market Value By Disease
Indication, 2015–2021 (US$ Mn)
Table 09: Latin America Cancer Supportive Care Products Market Value By Distribution
Channel, 2015–2021 (US$ Mn)
Table 10: Europe Cancer Supportive Care Products Market Value by Drug Class, 2015–2021
(US$ Mn)
Table 11: Europe Cancer Supportive Care Products Market Value By Disease Indication, 2015–
2021 (US$ Mn)
Table 12: Europe Cancer Supportive Care Products Market Value By Distribution Channel,
2015–2021 (US$ Mn)
Table 13: APAC Cancer Supportive Care Products Market Value by Drug Class, 2015–2021
(US$ Mn)
Table 14: APAC Cancer Supportive Care Products Market Value By Disease Indication, 2015–
2021 (US$ Mn)
Table 15: APAC Cancer Supportive Care Products Market Value By Distribution Channel,
2015–2021 (US$ Mn)
Table 16: MEA Cancer Supportive Care Products Market Value by Drug Class, 2015–2021
(US$ Mn)
Persistence Market Research
15
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Table 17: MEA Cancer Supportive Care Products Market Value By Disease Indication, 2015–
2021 (US$ Mn)
Table 18: MEA Cancer Supportive Care Products Market Value By Distribution Channel, 2015–
2021 (US$ Mn)
List of Figures
Figure 01: Global Oncology Drug Market Value (US$ Mn) 2014–2021
Figure 02: Global Cancer Supportive Care Drug Market – Scenario Forecast, 2015–2021 (US$
Mn)
Figure 03: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 04: Global Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 05: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison By Drug
Class, 2015–2021
Figure 06: Cancer Supportive Care Products Market Value Share & BPS Analysis By Drug
Class, 2015 & 2021
Figure 07: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Nonsteroidal Anti-inflammatory Drugs, 2015–2021
Figure 08: Global Cancer Supportive Care Products Market Absolute $ Opportunity By
Nonsteroidal Anti-inflammatory Drugs, 2015–2021
Figure 09: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Antiinfective, 2015–2021
Figure 10: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Antiinfective, 2015–2021
Figure 11: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Antiemetics, 2015–2021
Figure 12: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Antiemetics, 2015–2021
Figure 13: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%)
Monoclonal Antibodies, 2015–2021
Figure 14: Global Cancer Supportive Care Products Market Absolute $ Opportunity
Monoclonal Antibody, 2015–2021
Persistence Market Research
16
By
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Figure 15: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Erythropoietin Stimulating Agent, 2015–2021
Figure 16: Global Cancer Supportive Care Products Market Absolute $ Opportunity By
Erythropoietin Stimulating Agent, 2015–2021
Figure 17: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Opioid Analgesics, 2015–2021
Figure 18: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Opioid
Analgesics, 2015–2021
Figure 19: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Bisphosphonates, 2015–2021
Figure 20: Global Cancer Supportive Care Products Market Absolute $ Opportunity By
Bisphosphonates, 2015–2021
Figure 21: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Granulocyte Colony Stimulating Factor, 2015–2021
Figure 22: Global Cancer Supportive Care Products Market Absolute $ Opportunity By
Granulocyte Colony Stimulating Factor, 2015–2021
Figure 23: Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug
Class, 2015–2021
Figure 24: Global Cancer Supportive Care Products Market Attractiveness Analysis By
Indication, 2015–2021
Figure 25: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison by
Indication, 2015–2021
Figure 26: Cancer Supportive Care Products Market Value Share & BPS Analysis by Indication,
2015 & 2021
Figure 27: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Lung
Cancer, 2015–2021
Figure 28: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Lung
Cancer, 2015–2021
Figure 29: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Breast Cancer, 2015–2021
Figure 30: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Breast
Cancer, 2015–2021
Figure 31: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Prostate Cancer, 2015–2021
Persistence Market Research
17
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Figure 32: Global Cancer Supportive Care Products Market Absolute $ Opportunity by
Prostate Cancer, 2015–2021
Figure 33: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Liver
Cancer, 2015–2021
Figure 34: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Liver
Cancer, 2015–2021
Figure 35: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Bladder Cancer, 2015–2021
Figure 36: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Bladder
Cancer, 2015–2021
Figure 37: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Leukaemia, 2015–2021
Figure 38: Global Cancer Supportive Care Products Market Absolute $ Opportunity by
Leukaemia, 2015–2021
Figure 39: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Ovarian Cancer, 2015–2021
Figure 40: Global Cancer Supportive Care Products Market Absolute $ Opportunity by
Ovarian Cancer, 2015–2021
Figure 41: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Melanoma, 2015–2021
Figure 42: Global Cancer Supportive Care Products Market Absolute $ Opportunity by
Melanoma, 2015–2021
Figure 43: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Other
Cancer, 2015–2021
Figure 44: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Other
Cancer 2015–2021
Figure 45: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison by
Distribution Channel, 2015–2021
Figure 46: Cancer Supportive Care Products Market Value Share & BPS Analysis by
Distribution Channel, 2015 & 2021
Figure 47: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Hospital Pharmacies, 2015–2021
Figure 48: Global Cancer Supportive Care Products Market Absolute $ Opportunity by
Hospital Pharmacies, 2015–2021
Persistence Market Research
18
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Figure 49: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Retail
Pharmacies, 2015–2021
Figure 50: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Retail
Pharmacies, 2015–2021
Figure 51: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By
Compounding Pharmacies, 2015–2021
Figure 52: Global Cancer Supportive Care Products Market Absolute $ Opportunity by
Compounding Pharmacies, 2015–2021
Figure 53: Global Cancer Supportive Care Products Market Attractiveness Analysis by
Distribution Channel, 2015–2021
Figure 54: Cancer Supportive Care Products Market Y-o-Y Growth Comparison By Region,
2015–2021
Figure 55: Cancer Supportive Care Products Market Value Share & BPS Analysis By Region,
2015 & 2021
Figure 56: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for North
America Region, 2015–2021
Figure 57: Global Cancer Supportive Care Products Market Absolute $ Opportunity for North
America Region, 2015–2021
Figure 58: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Latin
America Region, 2015–2021
Figure 59: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Latin
America Region, 2015–2021
Figure 60: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for
Europe Region, 2015–2021
Figure 61: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Europe
Region, 2015–2021
Figure 62: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Asia
Pacific Region, 2015–2021
Figure 63: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Asia
Pacific Region, 2015–2021
Figure 64: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for
Middle East and Africa Region, 2015–2021
Figure 65: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Middle
East and Africa Region, 2015–2021
Persistence Market Research
19
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Figure 66: Global Cancer Supportive Care Products Market Attractiveness Analysis by Region,
2015–2021
Figure 67: U.S. Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 68: U.S. Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 69: Canada Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 70: Canada Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 71: North America Cancer Supportive Care Products Market Attractiveness Analysis by
Drug Class, 2015–2021
Figure 72: North America Cancer Supportive Care Products Market Attractiveness Analysis by
Indication, 2015–2021
Figure 73: North America Cancer Supportive Care Products Market Attractiveness Analysis by
Distribution Channel, 2015–2021
Figure 74: North America Cancer Supportive Care Products Market Attractiveness Analysis by
Country, 2015–2021
Figure 75: Argentina Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) ,
2015–2021
Figure 76: Argentina Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 77: Brazil Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 78: Brazil Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 79: Mexico Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 80: Mexico Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 81: Rest of Latin America Cancer Supportive Care Products Market Value & Y-o-Y
Growth (%), 2015–2021
Figure 82: Rest of Latin America Cancer Supportive Care Products Market Absolute $
Opportunity, 2015–2021
Figure 83: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by
Drug Class, 2015–2021
Persistence Market Research
20
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Figure 84: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by
Indication, 2015–2021
Figure 85: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by
Distribution Channel, 2015–2021
Figure 86: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by
Country, 2015–2021
Figure 87: Germany Cancer Supportive Care Products Market Value & Y-o-Y Growth (%),
2015–2021
Figure 88: Germany Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 89: U.K. Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 90: U.K. Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 91: France Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 92: France Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 93: Italy Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 94: Italy Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 95: Spain Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 96: Spain Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 97: Nordic Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 98: Nordic Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 99: Russia Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 100: Russia Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 101: Rest Of Europe Cancer Supportive Care Products Market Value & Y-o-Y Growth
(%), 2015–2021
Persistence Market Research
21
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Figure 102: Rest Of Europe Cancer Supportive Care Products Market Absolute $ Opportunity,
2015–2021
Figure 103: Europe Cancer Supportive Care Products Market Attractiveness Analysis by Drug
Class, 2015–2021
Figure 104: Europe Cancer Supportive Care Products Market Attractiveness Analysis By
Indication, 2015–2021
Figure 105: Europe Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel, 2015–2021
Figure 106: Europe Cancer Supportive Care Products Market Attractiveness Analysis By
Country, 2015–2021
Figure 107: Greater China Cancer Supportive Care Products Market Value & Y-o-Y Growth (%),
2015–2021
Figure 108: Greater China Cancer Supportive Care Products Market Absolute $ Opportunity,
2015–2021
Figure 109: India Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 110: India Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 111: Japan Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 112: Japan Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–
2021
Figure 113: Australia and New Zealand Cancer Supportive Care Products Market Value & Y-oY Growth (%), 2015–2021
Figure 114: Australia and New Zealand Cancer Supportive Care Products Market Absolute $
Opportunity, 2015–2021
Figure 115: Rest of APAC Cancer Supportive Care Products Market Value & Y-o-Y Growth (%),
2015–2021
Figure 116: Rest of APAC Cancer Supportive Care Products Market Absolute $ Opportunity,
2015–2021
Figure 117: APAC Cancer Supportive Care Products Market Attractiveness Analysis by Drug
Class, 2015–2021
Figure 118: APAC Cancer Supportive Care Products Market Attractiveness Analysis By
Indication, 2015–2021
Persistence Market Research
22
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
Figure 119: APAC Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel, 2015–2021
Figure 120: APAC Cancer Supportive Care Products Market Attractiveness Analysis By
Country, 2015–2021
Figure 121: GCC Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–
2021
Figure 122: GCC America Cancer Supportive Care Products Market Absolute $ Opportunity,
2015–2021
Figure 123: South Africa Cancer Supportive Care Products Market Value & Y-o-Y Growth (%),
2015–2021
Figure 124: South Africa Cancer Supportive Care Products Market Absolute $ Opportunity,
2015–2021
Figure 125: Rest Of MEA Cancer Supportive Care Products Market Value & Y-o-Y Growth (%),
2015–2021
Figure 126: Rest Of MEA Cancer Supportive Care Products Market Absolute $ Opportunity,
2015–2021
Figure 127: MEA Cancer Supportive Care Products Market Attractiveness Analysis by Drug
Class, 2015–2021
Figure 128: MEA Cancer Supportive Care Products Market Attractiveness Analysis By
Indication, 2015–2021
Figure 129: MEA Cancer Supportive Care Products Market Attractiveness Analysis By
Distribution Channel, 2015–2021
Figure 130: MEA Cancer Supportive Care Products Market Attractiveness Analysis By
Country, 2015–2021
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in
syndicated research, custom research, and consulting services. PMR boasts market research
expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy
and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and
Shipping and Transportation industries. The company draws from its multi-disciplinary
capabilities and high-pedigree team of analysts to share data that precisely corresponds to
clients’ business needs.
Persistence Market Research
23
Global Cancer Supportive Care Products Market - Market is
expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%
PMR stands committed to bringing more accuracy and speed to clients’ business decisions.
From ready-to-purchase market research reports to customized research solutions, PMR’s
engagement models are highly flexible without compromising on its deep-seated research
values.
Contact Us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
Persistence Market Research
24